A model for identifying HERG K+ channel blockers

被引:109
作者
Aronov, AM [1 ]
Goldman, BB [1 ]
机构
[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
HERG; QT prolongation; binary classification; pharmacophore; ensembles;
D O I
10.1016/j.bmc.2004.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acquired long QT syndrome (LQTS) occurs frequently as a side effect of blockade of cardiac HERG K+ channels by commonly used medications. A large number of structurally diverse compounds have been shown to inhibit K+ current through HERG. There is considerable interest in developing in silico tools to filter out potential HERG blockers early in the drug discovery process. We describe a binary classification model that combines a 21) topological similarity filter with a 3D pharmacophore ensemble procedure to discriminate between HERG actives and inactives with an overall accuracy of 82%, with false negative and false positive rates of 29% and 15%, respectively. This model should be generally applicable in virtual library counterscreening against HERG. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2307 / 2315
页数:9
相关论文
共 54 条
  • [1] *ADV CHEM DEV, ACD LABS
  • [2] Effects of fluoroquinolones on HERG currents
    Bischoff, U
    Schmidt, C
    Netzer, R
    Pongs, O
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (03) : 341 - 343
  • [3] A rapid computational method for lead evolution:: Description and application to α1-adrenergic antagonists
    Bradley, EK
    Beroza, P
    Penzotti, JE
    Grootenhuis, PDJ
    Spellmeyer, DC
    Miller, JL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) : 2770 - 2774
  • [4] BUYCK C, 2002, 14 EUR S QUANT STRUC
  • [5] ATOM PAIRS AS MOLECULAR-FEATURES IN STRUCTURE ACTIVITY STUDIES - DEFINITION AND APPLICATIONS
    CARHART, RE
    SMITH, DH
    VENKATARAGHAVAN, R
    [J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1985, 25 (02): : 64 - 73
  • [6] Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers
    Cavalli, A
    Poluzzi, E
    De Ponti, F
    Recanatini, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) : 3844 - 3853
  • [7] Cavero I, 2000, Expert Opin Pharmacother, V1, P947, DOI 10.1517/14656566.1.5.947
  • [8] Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels
    Chen, J
    Seebohm, G
    Sanguinetti, MC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12461 - 12466
  • [9] QT interval prolongation by noncardiovascular drugs: issues and solutions for novel drug development
    Crumb, W
    Cavero, I
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (07): : 270 - 280
  • [10] *DAYL CHEM INF, DAYL CHEM INF SOFTW